BR9306058A - Derivados de amina de hidrocarbonetos oxo- e hidroxi- substituidos - Google Patents
Derivados de amina de hidrocarbonetos oxo- e hidroxi- substituidosInfo
- Publication number
- BR9306058A BR9306058A BR9306058A BR9306058A BR9306058A BR 9306058 A BR9306058 A BR 9306058A BR 9306058 A BR9306058 A BR 9306058A BR 9306058 A BR9306058 A BR 9306058A BR 9306058 A BR9306058 A BR 9306058A
- Authority
- BR
- Brazil
- Prior art keywords
- oxo
- hydroxy
- amine derivatives
- substituted hydrocarbons
- hydrocarbons
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/02—Compounds containing any of the groups, e.g. carbazates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPL130492 | 1992-03-11 | ||
PCT/AU1993/000103 WO1993018006A1 (en) | 1992-03-11 | 1993-03-11 | Amine derivatives of oxo- and hydroxy-substitued hydrocarbons |
APAP/P/1993/000504A AP395A (en) | 1992-03-11 | 1993-03-29 | Amine derivatives of oxo- and hydroxy-substituted hydrocarbons. |
CN93119079A CN1090612C (zh) | 1992-03-11 | 1993-09-11 | 氧代和羟基取代的烃的胺衍生物 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9306058A true BR9306058A (pt) | 1997-11-18 |
Family
ID=36869978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9306058A BR9306058A (pt) | 1992-03-11 | 1993-03-11 | Derivados de amina de hidrocarbonetos oxo- e hidroxi- substituidos |
Country Status (9)
Country | Link |
---|---|
US (2) | US5679688A (pt) |
EP (1) | EP0633881B1 (pt) |
JP (1) | JPH07504654A (pt) |
CN (1) | CN1090612C (pt) |
BR (1) | BR9306058A (pt) |
CA (1) | CA2130754C (pt) |
NZ (1) | NZ249789A (pt) |
RU (1) | RU2126794C1 (pt) |
WO (1) | WO1993018006A1 (pt) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5753652A (en) * | 1991-07-03 | 1998-05-19 | Novartis Corporation | Antiretroviral hydrazine derivatives |
MXPA93002392A (es) | 1992-03-11 | 2005-02-04 | Narhex Ltd | Derivados amino de hidrocarburos-oxo e hidroxi-substituidos. |
US6071895A (en) * | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
US5679688A (en) * | 1992-03-11 | 1997-10-21 | Narhex Limited | Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons |
US5559256A (en) * | 1992-07-20 | 1996-09-24 | E. R. Squibb & Sons, Inc. | Aminediol protease inhibitors |
DE59303870D1 (de) * | 1992-12-23 | 1996-10-24 | Ciba Geigy Ag | Antiretrovirale hydrazinderivate |
US5461067A (en) * | 1993-02-25 | 1995-10-24 | Abbott Laboratories | Retroviral protease inhibiting compounds |
ATE149486T1 (de) * | 1993-11-02 | 1997-03-15 | Hoechst Ag | Substituierte heterocyclische carbonsäureamide, ihre herstellung und ihre verwendung als arzneimittel |
AU3150395A (en) * | 1994-08-09 | 1996-03-07 | Abbott Laboratories | Retroviral protease inhibiting 1,2,4-triazacycloheptanes |
US5849911A (en) * | 1996-04-22 | 1998-12-15 | Novartis Finance Corporation | Antivirally active heterocyclic azahexane derivatives |
AU2959397A (en) * | 1996-05-31 | 1998-01-05 | Novartis Ag | Process for the preparation of hydrazine derivatives useful as intermediates for the preparation of peptide analogues |
PT915841E (pt) | 1996-07-17 | 2002-08-30 | Novartis Ag | Derivados anilinopeptidos |
US6054446A (en) | 1997-12-24 | 2000-04-25 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
CA2359112A1 (en) * | 1999-01-22 | 2000-07-27 | Elan Pharmaceuticals, Inc. | Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
JP2002535314A (ja) * | 1999-01-22 | 2002-10-22 | エラン ファーマシューティカルズ,インコーポレイテッド | Vla−4により媒介される白血球接着を阻害する化合物 |
CA2357781A1 (en) | 1999-01-22 | 2000-07-27 | Elan Pharmaceuticals, Inc. | Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
US6436904B1 (en) * | 1999-01-25 | 2002-08-20 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
ATE334121T1 (de) * | 1999-01-29 | 2006-08-15 | Kaneka Corp | Verfahren zur herstellung von threo-1,2-epoxy-3- amino-4-phenylbutan-derivaten |
DE60009883T2 (de) | 1999-03-01 | 2005-04-07 | Elan Pharmaceuticals, Inc., San Francisco | Alpha-aminoessigsäure derivate als alpha 4 beta 7- rezeptor antagonisten |
CA2483959A1 (en) * | 2001-08-28 | 2003-03-13 | Elan Pharmaceuticals, Inc. | Method for treating alzheimer's disease using quinaldoyl-amine derivatives of oxo- and hydroxy-substituted hydrocarbons |
US7157489B2 (en) * | 2002-03-12 | 2007-01-02 | The Board Of Trustees Of The University Of Illinois | HIV protease inhibitors |
TW200307671A (en) * | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
TWI281470B (en) * | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
WO2005061487A1 (en) * | 2003-12-11 | 2005-07-07 | Abbott Laboratories | Hiv protease inhibiting compounds |
ATE539074T1 (de) * | 2003-12-11 | 2012-01-15 | Abbott Lab | Die hiv-protease hemmende verbindungen |
US6992177B1 (en) | 2004-12-10 | 2006-01-31 | Roche Diagnostics Operations, Inc. | Saquinavir derivatives useful in immunoassay |
GB0503056D0 (en) * | 2005-02-14 | 2005-03-23 | Smithkline Beecham Corp | Chemical compounds |
NZ567270A (en) * | 2005-09-29 | 2011-06-30 | Elan Pharm Inc | Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4 |
CN101273035A (zh) * | 2005-09-29 | 2008-09-24 | 伊兰制药公司 | 抑制由vla-4介导的白细胞粘附的氨基甲酸酯化合物 |
EA017110B1 (ru) * | 2006-02-27 | 2012-09-28 | Элан Фамэсьютикэлс, Инк. | ПИРИМИДИНИЛСУЛЬФОНАМИДНЫЕ СОЕДИНЕНИЯ (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ ПИРИМИДИНИЛСУЛЬФОНАМИДНЫХ СОЕДИНЕНИЙ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, ОПОСРЕДОВАННОГО ИНТЕГРИНОМ α4, СПОСОБ СНИЖЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ВОСПАЛИТЕЛЬНОГО КОМПОНЕНТА ЗАБОЛЕВАНИЯ ИЛИ АУТОИММУННОГО ОТВЕТА |
ES2574831T3 (es) | 2006-07-21 | 2016-06-22 | Gilead Sciences, Inc. | Inhibidores de la proteasa antivirales |
MX2011011326A (es) * | 2009-04-27 | 2012-02-13 | Elan Pharm Inc | Antagonistas de piridinona de las integrinas alfa-4. |
CN105669749B (zh) * | 2014-08-14 | 2018-03-30 | 赫斯(西安)生物科技有限公司 | 抗病毒药物及组合物 |
CN104628771B (zh) * | 2014-08-14 | 2016-05-11 | 赫斯(西安)生物科技有限公司 | 抗病毒药物及其药物组合物 |
JOP20180009A1 (ar) | 2017-02-06 | 2019-01-30 | Gilead Sciences Inc | مركبات مثبط فيروس hiv |
TWI829205B (zh) | 2018-07-30 | 2024-01-11 | 美商基利科學股份有限公司 | 抗hiv化合物 |
Family Cites Families (141)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3330857A (en) * | 1963-07-01 | 1967-07-11 | Pfizer & Co C | N-carbazoylamino acid intermediates for polypeptides |
US5142056A (en) * | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US5252477A (en) * | 1987-06-01 | 1993-10-12 | The United States Of America As Represented By The United States Department Of Health And Human Services | Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation |
EP0395664A1 (en) * | 1987-10-21 | 1990-11-07 | The Upjohn Company | Renin inhibitors containing a (1-amino-2-hydroxy-2-heterocyclic) ethyl moiety |
IL89900A0 (en) | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
EP0413750A1 (en) * | 1988-05-03 | 1991-02-27 | The Upjohn Company | Renin inhibitory peptides containing a substituted phenoxyacetyle group |
IL90218A0 (en) * | 1988-05-13 | 1989-12-15 | Abbott Lab | Retroviral protease inhibitors |
US5248667A (en) * | 1988-05-27 | 1993-09-28 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Method of treating psoriasis using synthetic peptide compositions |
CA1340588C (en) | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
CA1340748C (en) * | 1988-07-13 | 1999-09-14 | Stephen Oroszlan | Synthetic hiv protease gene and method for its expression |
DK414389A (da) | 1988-08-24 | 1990-02-26 | Merck & Co Inc | Farmaceutisk praeparat indeholdende et aminosyrederivat med renin-inhibitorisk virkning |
IL91307A0 (en) * | 1988-08-24 | 1990-03-19 | Merck & Co Inc | Hiv protease inhibitors and pharmaceutical compositions for the treatment of aids containing them |
EP0361341A3 (en) * | 1988-09-28 | 1991-07-03 | Miles Inc. | Therapeutics for aids based on inhibitors of hiv protease |
IL92011A0 (en) * | 1988-10-19 | 1990-07-12 | Abbott Lab | Heterocyclic peptide renin inhibitors |
DE3840452A1 (de) * | 1988-12-01 | 1990-06-07 | Hoechst Ag | (beta)-amino-boronsaeure-derivate |
DE3841520A1 (de) * | 1988-12-09 | 1990-06-13 | Hoechst Ag | Enzymhemmende harnstoffderivate von dipeptiden, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung |
US5215968A (en) * | 1988-12-10 | 1993-06-01 | Hoechst Aktiengesellschaft | Dipeptide derivatives having an enzyme inhibitory action |
DE3842067A1 (de) * | 1988-12-14 | 1990-06-21 | Hoechst Ag | Enzym-hemmende aminosaeurederivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung |
EP0374098A3 (de) | 1988-12-15 | 1991-05-02 | Ciba-Geigy Ag | Retrovirale Proteasehemmer |
DE3842197A1 (de) * | 1988-12-15 | 1990-06-21 | Hoechst Ag | Rasch spaltbares substrat fuer die hiv-protease |
US5198426A (en) * | 1988-12-30 | 1993-03-30 | Warner-Lambert Company | Renin inhibitors containing c-terminal dihydroxy amides |
CA2010531A1 (en) * | 1989-03-06 | 1990-09-06 | Werner Neidhart | Amino acid derivatives |
US5342922A (en) | 1989-03-08 | 1994-08-30 | Washington University | Inhibitors of retroviral protease |
US5086165A (en) * | 1989-03-08 | 1992-02-04 | Washington University | Inhibitors of retroviral protease with a ketomethylene isosteric replaced amide bond |
KR920700221A (ko) * | 1989-04-18 | 1992-02-19 | 원본미기재 | 극성 n-말단기들을 갖는 신규 리닌 억제인자 펩티드 |
DE3913272A1 (de) * | 1989-04-22 | 1990-10-25 | Hoechst Ag | Dipeptid-derivate mit enzym-inhibitorischer wirkung |
US5256677A (en) * | 1989-05-23 | 1993-10-26 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US5151438A (en) * | 1989-05-23 | 1992-09-29 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US5126326A (en) * | 1989-06-06 | 1992-06-30 | Bio-Mega, Inc. | Enzyme inhibiting peptide derivatives |
US5212157A (en) * | 1989-06-06 | 1993-05-18 | Bio-Mega, Inc. | Enzyme inhibitors |
AU6066390A (en) * | 1989-07-19 | 1991-02-22 | Upjohn Company, The | Peptides containing diamino-glycols as transition-state mimics |
EP0421109A3 (en) * | 1989-09-11 | 1992-01-08 | American Cyanamid Company | Screening methods for protease inhibitors |
EP0428849A3 (en) * | 1989-09-28 | 1991-07-31 | Hoechst Aktiengesellschaft | Retroviral protease inhibitors |
DE4033062A1 (de) * | 1990-10-18 | 1992-04-23 | Merck Patent Gmbh | Aminosaeurederivate |
CA2066644A1 (en) * | 1989-10-27 | 1991-04-28 | Robert L. Heinrikson | Method for treating hiv and other retroviruses and compounds useful therefor |
US5221665A (en) * | 1989-10-27 | 1993-06-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | N-substituted amides |
AU638774B2 (en) * | 1989-11-20 | 1993-07-08 | Eli Lilly And Company | Methods of treating retroviral infection |
US5194605A (en) * | 1989-12-08 | 1993-03-16 | Merck & Co., Inc. | Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs |
EP0432974A1 (en) | 1989-12-08 | 1991-06-19 | Merck & Co. Inc. | Cyclic renin inhibitors |
CA2031745A1 (en) | 1989-12-08 | 1991-06-09 | William J. Greenlee | Cyclic renin inhibitors containing 2-substituted(3s, 4s)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3s, 4s)-5-cyclohexyl-3,4-dihydroxy-pentanoic acid or 2 -substituted (4s, 5s)-5-amino-6- yclohexyl-4-hydroxyhexanoic acid or its analogs |
US5254682A (en) * | 1989-12-08 | 1993-10-19 | Merck & Co., Inc. | Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs |
GB8927913D0 (en) | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
GB8927915D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Novel alcohols |
DE3941235A1 (de) * | 1989-12-14 | 1991-06-20 | Bayer Ag | Neue peptide, ihre herstellung und ihre verwendung in arzneimitteln |
CA2032259A1 (en) * | 1989-12-18 | 1991-06-19 | Wayne J. Thompson | Hiv protease inhibitors useful for the treatment of aids |
DE69011130T2 (de) * | 1989-12-18 | 1995-03-16 | Transgene Sa | Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen. |
US5164300A (en) * | 1989-12-28 | 1992-11-17 | Washington University | Method for determining activity of retroviral protease |
US5011910A (en) * | 1989-12-28 | 1991-04-30 | Washington University | Reagent and method for determining activity of retroviral protease |
DE4001236A1 (de) * | 1990-01-18 | 1991-07-25 | Bayer Ag | Neue peptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel, insbesondere als arzneimittel gegen retroviren |
EP0438311A3 (en) | 1990-01-19 | 1992-07-01 | Merck & Co. Inc. | Di- and tripeptide renin inhibitors |
US5221667A (en) * | 1990-01-22 | 1993-06-22 | Warner-Lambert Company | Renin inhibiting peptides having an α-heteroatom amino acid at the P3 position |
CA2036397C (en) * | 1990-02-23 | 2000-12-12 | Paul Cates Anderson | Hiv protease inhibitors containing derived amino acid units |
CA2036413C (en) * | 1990-02-23 | 2000-12-12 | Paul Cates Anderson | Hiv protease inhibitors |
CA2036398C (en) * | 1990-02-23 | 2000-06-13 | Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee | Hiv protease inhibiting agents |
GB9005829D0 (en) * | 1990-03-15 | 1990-05-09 | Proteus Biotech Ltd | Synthetic polypeptides |
IL98260A0 (en) * | 1990-06-01 | 1992-06-21 | Ciba Geigy Ag | Hiv protease inhibiting oligopeptides,process for their preparation and pharmaceutical compositions containing them |
AU8205491A (en) * | 1990-06-01 | 1991-12-31 | Du Pont Merck Pharmaceutical Company, The | 1,4-diamino-2,3-dihydroxybutanes |
EP0532693A1 (en) * | 1990-06-01 | 1993-03-24 | The Du Pont Merck Pharmaceutical Company | 1,4-diamino-2,3-dihydroxybutanes |
US5248606A (en) * | 1990-06-11 | 1993-09-28 | Dowelanco | Dna encoding inactive precursor and active forms of maize ribosome inactivating protein |
US5141735A (en) * | 1990-06-18 | 1992-08-25 | Hoffman-La Roche, Inc. | Substituted amino-benzodiazepines having anitviral activity |
US5223633A (en) * | 1990-06-30 | 1993-06-29 | Bayer Aktiengesellschaft | Preparation of sec. or tert. alcohols |
DE4021007A1 (de) * | 1990-07-02 | 1992-01-09 | Hoechst Ag | Aminodiol-derivate |
JPH06501681A (ja) * | 1990-07-06 | 1994-02-24 | スミスクライン・ビーチャム・コーポレイション | レトロウイルス・プロテアーゼの阻害剤 |
CA2086414A1 (en) * | 1990-07-06 | 1992-01-07 | Geoffrey B. Dreyer | Retroviral protease inhibitors |
JPH05508846A (ja) * | 1990-07-06 | 1993-12-09 | スミスクライン・ビーチャム・コーポレイション | アスパラギン酸プロテアーゼ抑制剤 |
EP0538383A1 (en) * | 1990-07-06 | 1993-04-28 | Smithkline Beecham Corporation | Inhibitors of aspartic proteases |
WO1992003472A1 (en) * | 1990-08-24 | 1992-03-05 | The Upjohn Company | Peptides containing amino-polyols as transition-state mimics |
EP0475231A1 (en) * | 1990-09-10 | 1992-03-18 | F. Hoffmann-La Roche Ag | Benzodiazepines |
US5171662A (en) * | 1990-09-13 | 1992-12-15 | The Upjohn Company | Method of detecting HIV protease activity |
US5183826A (en) * | 1990-09-25 | 1993-02-02 | Merck & Co., Inc. | Antiviral agent |
JPH06502403A (ja) * | 1990-10-10 | 1994-03-17 | ジ・アップジョン・カンパニー | 遷移状態インサートとして置換1,4−ジアミンを含有するペプチド |
US5192668A (en) * | 1990-10-11 | 1993-03-09 | Merck & Co., Inc. | Synthesis of protease inhibitor |
CA2052907A1 (en) | 1990-10-11 | 1992-04-12 | Joseph P. Vacca | Hiv protease inhibitors having symmetrical structure |
US5188950A (en) * | 1990-10-11 | 1993-02-23 | Merck & Co., Inc. | Method of preparing HIV protease inhibitors |
US5187074A (en) * | 1990-10-11 | 1993-02-16 | Merck & Co., Inc. | Method of hydroxylation with ATCC 55086 |
US5137876A (en) * | 1990-10-12 | 1992-08-11 | Merck & Co., Inc. | Nucleoside antiviral and anti-inflammatory compounds and compositions and methods for using same |
EP0483403A1 (en) * | 1990-10-31 | 1992-05-06 | Hoechst Aktiengesellschaft | Derivatives of amino acids as inhibitors of renin, methods for their preparation, medicaments containing them and their use |
ES2151618T3 (es) * | 1990-11-19 | 2001-01-01 | Monsanto Co | Inhibidores de proteasas retrovirales. |
CA2096407C (en) * | 1990-11-19 | 2007-10-02 | Kathryn Lea Reed | Retroviral protease inhibitors |
EP0558603B1 (en) * | 1990-11-19 | 1998-08-26 | Monsanto Company | Retroviral protease inhibitors |
CA2055685A1 (en) | 1990-11-19 | 1992-05-20 | Samuel L. Graham | Hiv protease inhibitors having polyether substituents |
HU9301446D0 (en) * | 1990-11-19 | 1993-11-29 | Monsanto Co | Inhibitors or fetrovirus protease |
IE20010533A1 (en) * | 1990-11-20 | 2003-03-05 | Abbott Lab | Intermediates for preparing retroviral protease inhibiting compounds |
DE4037437A1 (de) * | 1990-11-24 | 1992-05-27 | Hoechst Ag | Aminodiol-derivate |
WO1992009297A1 (en) * | 1990-11-30 | 1992-06-11 | Smithkline Beecham Corporation | Hiv protease inhibitors |
CA2056911C (en) * | 1990-12-11 | 1998-09-22 | Yuuichi Nagano | Hiv protease inhibitors |
EP0491218A1 (en) * | 1990-12-17 | 1992-06-24 | F. Hoffmann-La Roche Ag | Benzodiazepinones |
CA2057369A1 (en) | 1990-12-17 | 1992-06-18 | Ann E. Decamp | Stereocontrolled production of hydroxyester, hydroxyamide, and lactone compounds from chiral alpha-amino aldehydes |
EP0492136A3 (en) * | 1990-12-20 | 1993-05-26 | American Cyanamid Company | Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene |
EP0565631B1 (en) * | 1991-01-02 | 1996-09-18 | Merrell Pharmaceuticals Inc. | Anti-viral compounds |
AU647239B2 (en) * | 1991-02-08 | 1994-03-17 | Sankyo Company Limited | New beta-amino- alpha-hydroxycarboxylic acids and their use |
WO1992014696A2 (en) * | 1991-02-22 | 1992-09-03 | The Du Pont Merck Pharmaceutical Company | SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES |
WO1992017490A1 (en) * | 1991-04-04 | 1992-10-15 | The Upjohn Company | Phosphorus containing compounds as inhibitors of retroviruses |
US5430041A (en) * | 1991-05-10 | 1995-07-04 | Hoffmann-La Roche Inc. | Amino acid derivatives having antiviral activity |
US5235039A (en) * | 1991-06-10 | 1993-08-10 | Eli Lilly And Company | Substrates for hiv protease |
CA2070978A1 (en) | 1991-06-11 | 1992-12-12 | William J. Greenlee | Cyclic renin inhibitors |
CA2089890A1 (en) | 1991-06-20 | 1992-12-21 | Makoto Yoshihama | Prolyl endopeptidase inhibitors sna-115 and sna-115t, production thereof, and strain which produces said inhibitors |
PL294866A1 (en) * | 1991-06-21 | 1993-05-31 | Hoechst Ag | Method of obtaining novel rennin redtarding heterocyclic compounds |
PL294870A1 (pt) | 1991-06-21 | 1993-02-08 | Hoechst Ag | |
CA2072237A1 (en) | 1991-07-02 | 1993-01-03 | Merck & Co., Inc. | Stereoselective production of hydroxyamide compounds from chiral -amino epoxides |
US5169952A (en) * | 1991-07-02 | 1992-12-08 | Merck & Co., Inc. | Stereoselective production of hydroxyamide compounds from chiral α-amino epoxides |
CA2109326A1 (en) * | 1991-07-02 | 1993-01-03 | Andreas Billich | 4-amino-3-hydroxycarboxylic acid derivatives |
DE59207226D1 (de) * | 1991-07-03 | 1996-10-31 | Ciba Geigy Ag | Pharmakologisch wirksame Hydrazinderivate und Verfahren zu deren Herstellung |
CN1071930A (zh) | 1991-07-10 | 1993-05-12 | 伊莱利利公司 | 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂 |
IE922316A1 (en) * | 1991-07-17 | 1993-01-27 | Smithkline Beecham Corp | Retroviral protease inhibitors |
US5554728A (en) * | 1991-07-23 | 1996-09-10 | Nexstar Pharmaceuticals, Inc. | Lipid conjugates of therapeutic peptides and protease inhibitors |
DE4126485A1 (de) | 1991-08-10 | 1993-02-11 | Bayer Ag | Trifluormethyl-haltige pseudopeptide |
US5516784A (en) * | 1991-08-13 | 1996-05-14 | Schering Corporation | Anti-HIV (AIDS) agents |
CA2076204A1 (en) | 1991-08-16 | 1993-02-17 | Samuel L. Graham | Hiv protease inhibitors with n-terminal polyether substituents |
EP0534511A1 (en) | 1991-08-16 | 1993-03-31 | Merck & Co. Inc. | HIV protease inhibitors useful for the treatment of aids |
DE4128790A1 (de) | 1991-08-30 | 1993-03-04 | Bayer Ag | Neue substituierte 2,3-diaminosaeuren, verfahren zu ihrer herstellung und ihre verwendung als zwischenstufen fuer peptidische wirkstoffe |
PT100865A (pt) * | 1991-09-11 | 1994-01-31 | Smithkline Beckman Corp | Isosteros de peptido contendo um heterociclo, processo de preparacao dos mesmos seus intermediarios, uso e composicoes farmaceuticas |
EP0532466A3 (en) * | 1991-09-12 | 1993-06-16 | Ciba-Geigy Ag | Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use |
US5250563A (en) * | 1991-09-25 | 1993-10-05 | Merck & Co., Inc. | Inhibitors of HIV protease |
WO1993008184A1 (en) * | 1991-10-23 | 1993-04-29 | Merck & Co., Inc. | Hiv protease inhibitors |
DK0541168T3 (da) * | 1991-11-08 | 1998-05-11 | Merck & Co Inc | HIV-proteaseinhibitorer, som er egnede til behandling af AIDS |
FR2683723B1 (fr) | 1991-11-14 | 1995-05-19 | Mayoly Spindler Laboratoires | Nouveaux medicaments antiviraux actifs sur le virus vih. |
CA2084800A1 (en) | 1991-12-16 | 1993-06-17 | Joseph P. Vacca | Hiv protease inhibitors with an internal lactam ring |
AU3497293A (en) | 1992-02-26 | 1993-09-13 | F. Hoffmann-La Roche Ag | Benzodiazepinones and medicines containing them |
US5294737A (en) * | 1992-02-27 | 1994-03-15 | The Research Foundation State University Of New York | Process for the production of chiral hydroxy-β-lactams and hydroxyamino acids derived therefrom |
US5679688A (en) * | 1992-03-11 | 1997-10-21 | Narhex Limited | Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons |
EP0560268B1 (en) | 1992-03-13 | 1995-01-04 | Bio-Mega/Boehringer Ingelheim Research Inc. | Substituted pipecolinic acid derivatives as HIV protease inhibitors |
CA2091151A1 (en) | 1992-03-13 | 1993-09-14 | Kwan Y. Hui | Retroviral protease inhibitors |
ZA931777B (en) | 1992-03-13 | 1993-09-23 | Bio Mega Boehringer Ingelheim | Substituted pyrrolidine derivatives as HIV protease inhibitors. |
TW217410B (pt) | 1992-04-01 | 1993-12-11 | Ciba Geigy | |
US5231153A (en) * | 1992-04-06 | 1993-07-27 | The Goodyear Tire & Rubber Company | Anionic polymerization of conjugated dienes modified with alkyltetrahydrofurfuryl ethers |
DE69322127T2 (de) | 1992-05-13 | 1999-06-24 | Japan Energy Corp., Tokio/Tokyo | Verfahren zur Herstellung von Peptidderivaten und ihrer Salze |
DE4215874A1 (de) | 1992-05-14 | 1993-11-18 | Bayer Ag | Dithiolanylglycinhaltige HIV-Proteaseinhibitoren vom Hydroxyethylenisostertyp |
US5296604A (en) * | 1992-05-15 | 1994-03-22 | Miles Inc. | Proline derivatives and compositions for their use as inhibitors of HIV protease |
SI9300288A (sl) | 1992-06-16 | 1993-12-31 | Hoffmann La Roche | Benzodiazepini |
NO932130L (no) | 1992-06-19 | 1993-12-20 | Lilly Co Eli | Hemmere av HIV-protease som er nyttige for behandling av AIDS |
US5559256A (en) | 1992-07-20 | 1996-09-24 | E. R. Squibb & Sons, Inc. | Aminediol protease inhibitors |
DE4232173A1 (de) | 1992-09-25 | 1994-03-31 | Bayer Ag | 5-Oxo-dibenzo(a,d)cyclohepta-1,4-diene |
TW372972B (en) | 1992-10-23 | 1999-11-01 | Novartis Ag | Antiretroviral acyl compounds |
US5430150A (en) | 1992-12-16 | 1995-07-04 | American Cyanamid Company | Retroviral protease inhibitors |
MX9308016A (es) | 1992-12-22 | 1994-08-31 | Lilly Co Eli | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. |
US5491166A (en) | 1992-12-22 | 1996-02-13 | Eli Lilly And Company | Inhibitors of HIV protease useful for the treatment of AIDS |
US5434265A (en) | 1992-12-22 | 1995-07-18 | Eli Lilly And Company | Inhibitors of HIV protease |
DE69329544T2 (de) | 1992-12-22 | 2001-05-31 | Eli Lilly And Co., Indianapolis | HIV Protease hemmende Verbindungen |
US5554653A (en) | 1992-12-22 | 1996-09-10 | Eli Lilly And Company | Inhibitors of HIV protease useful for the treatment of AIDS |
DE59303870D1 (de) | 1992-12-23 | 1996-10-24 | Ciba Geigy Ag | Antiretrovirale hydrazinderivate |
-
1993
- 1993-03-11 US US08/295,855 patent/US5679688A/en not_active Expired - Fee Related
- 1993-03-11 EP EP93906370A patent/EP0633881B1/en not_active Expired - Lifetime
- 1993-03-11 JP JP5515189A patent/JPH07504654A/ja not_active Ceased
- 1993-03-11 NZ NZ249789A patent/NZ249789A/en not_active IP Right Cessation
- 1993-03-11 RU RU94040859/04A patent/RU2126794C1/ru not_active IP Right Cessation
- 1993-03-11 BR BR9306058A patent/BR9306058A/pt not_active Application Discontinuation
- 1993-03-11 CA CA002130754A patent/CA2130754C/en not_active Expired - Fee Related
- 1993-03-11 WO PCT/AU1993/000103 patent/WO1993018006A1/en active IP Right Grant
- 1993-09-11 CN CN93119079A patent/CN1090612C/zh not_active Expired - Lifetime
-
1997
- 1997-07-25 US US08/900,733 patent/US5942504A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5942504A (en) | 1999-08-24 |
EP0633881A4 (en) | 1995-02-22 |
WO1993018006A1 (en) | 1993-09-16 |
CA2130754C (en) | 2005-02-08 |
RU94040859A (ru) | 1996-07-10 |
CN1100090A (zh) | 1995-03-15 |
JPH07504654A (ja) | 1995-05-25 |
NZ249789A (en) | 1997-07-27 |
CA2130754A1 (en) | 1993-09-12 |
US5679688A (en) | 1997-10-21 |
EP0633881B1 (en) | 2003-10-29 |
EP0633881A1 (en) | 1995-01-18 |
CN1090612C (zh) | 2002-09-11 |
RU2126794C1 (ru) | 1999-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9306058A (pt) | Derivados de amina de hidrocarbonetos oxo- e hidroxi- substituidos | |
FI961739A (fi) | Amiinisuoloja klavulaanihapon valmistamiseksi | |
FI935223A0 (fi) | RAKE-mottagare med selektiv kombinering av straolar | |
PT83876B (pt) | Processo para a preparacao de derivados de butiramida n-substituidos | |
FI951192A0 (fi) | Kestomuovien iskumodifiointi | |
DE69324988D1 (de) | Überprüfung des Sprechers | |
DE69315662D1 (de) | Aminderivate als Korrosionsinhibitoren | |
FI931546A0 (fi) | Med signalexpansion foersedd mikroeffektdriver foer foerstaerkare/omvandlare | |
FI945085A0 (fi) | Yhdistelmä-neu-reseptoristimulaatiotekijä | |
DE69330497D1 (de) | Chinazolin-derivate | |
DE59309481D1 (de) | Synergistisch wirksame Herbizidkombinationen | |
ZA936059B (en) | Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase | |
DE59308714D1 (de) | Cyclobutan-benzol-derivate | |
MX9100998A (es) | Novedosos inhibidores de escualen sintetasa | |
DE69314072D1 (de) | Cephalosporin-Derivat | |
NO952288D0 (no) | Benzazepinon-derivater | |
NO940190L (no) | Anvendelse av alpha-ketoglutarat | |
BR9307043A (pt) | Processo para preparação de dinitro-tolueno | |
AP9300504A0 (en) | Amine derivatives of oxo-and hydroxy-substituted hydrocarbons | |
AU2480197A (en) | Amine derivatives of oxo- and hydroxy-substituted hydrocarbons | |
FI951212A (fi) | beta-metyylikarbapeneemivälituotteiden valmistus | |
GB9215274D0 (en) | Derivatives of(phenylethyl-beta-ol)amine | |
ZA932220B (en) | Amine derivatives of oxo- and hydroxa-substituted hydrocarbons | |
KR940017707U (ko) | Ussr c/v의 홀더 | |
ITRM910578A0 (it) | Procedimento per la purificazione di salgemma ottenuto elettrostaticamente |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
FC | Decision: refusal | ||
ND | Extension of time allowed | ||
B15K | Others concerning applications: alteration of classification |
Ipc: C07D 215/48 (2006.01), C07C 271/20 (2006.0 |